Topical fluconazole therapy of Candida keratitis

Cornea. 1996 Jul;15(4):373-5. doi: 10.1097/00003226-199607000-00007.

Abstract

A prospective clinical trial of topical fluconazole solution (2 mg/ml) was undertaken in six consecutive eyes of microbiologically proven Candida keratitis with abscess formation. All eyes responded well to the medical therapy. Average duration required for healing was 22.6 +/- 2.3 days. The findings of our study suggest that topical fluconazole is a safe and effective antifungal drug for the management of Candida keratitis with deep abscess.

Publication types

  • Clinical Trial

MeSH terms

  • Abscess / drug therapy
  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Candidiasis / drug therapy*
  • Child
  • Corneal Diseases / drug therapy
  • Female
  • Fluconazole / therapeutic use*
  • Humans
  • Keratitis / microbiology*
  • Male
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome

Substances

  • Fluconazole